Cargando…
MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion
The MICAL (Molecules Interacting with CasL) proteins catalyze actin oxidation-reduction reactions destabilizing F-actin in cytoskeletal dynamics. Here we show for the first time that MICAL2 mRNA is significantly over-expressed in aggressive, poorly differentiated/undifferentiated, primary human epit...
Autores principales: | Mariotti, Sara, Barravecchia, Ivana, Vindigni, Carla, Pucci, Angela, Balsamo, Michele, Libro, Rosaliana, Senchenko, Vera, Dmitriev, Alexey, Jacchetti, Emanuela, Cecchini, Marco, Roviello, Franco, Lai, Michele, Broccoli, Vania, Andreazzoli, Massimiliano, Mazzanti, Chiara M., Angeloni, Debora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811499/ https://www.ncbi.nlm.nih.gov/pubmed/26689989 |
Ejemplares similares
-
MICAL2 is essential for myogenic lineage commitment
por: Giarratana, Nefele, et al.
Publicado: (2020) -
Inducible Pluripotent Stem Cells to Model and Treat Inherited Degenerative Diseases of the Outer Retina: 3D-Organoids Limitations and Bioengineering Solutions
por: Andreazzoli, Massimiliano, et al.
Publicado: (2021) -
Enriching the Arsenal of Pharmacological Tools against MICAL2
por: Barravecchia, Ivana, et al.
Publicado: (2021) -
Increasing cell culture density during a developmental window prevents fated rod precursors derailment toward hybrid rod-glia cells
por: Barravecchia, Ivana, et al.
Publicado: (2023) -
The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration
por: Libro, Rosaliana, et al.
Publicado: (2017)